UK markets closed

Black Diamond Therapeutics, Inc. (BDTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.13+0.23 (+4.69%)
As of 01:19PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 253.42M
Enterprise value 147.32M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.17
Enterprise value/revenue N/A
Enterprise value/EBITDA -1.71

Trading information

Stock price history

Beta (5Y monthly) 2.65
52-week change 3170.72%
S&P500 52-week change 329.57%
52-week high 36.85
52-week low 31.43
50-day moving average 34.24
200-day moving average 33.31

Share statistics

Avg vol (3-month) 3604.27k
Avg vol (10-day) 3615.13k
Shares outstanding 551.72M
Implied shares outstanding 651.72M
Float 835.93M
% held by insiders 12.59%
% held by institutions 194.18%
Shares short (15 Mar 2024) 41.81M
Short ratio (15 Mar 2024) 42.78
Short % of float (15 Mar 2024) 45.58%
Short % of shares outstanding (15 Mar 2024) 43.50%
Shares short (prior month 15 Feb 2024) 41.88M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-34.33%
Return on equity (ttm)-70.94%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -86.02M
Net income avi to common (ttm)-82.44M
Diluted EPS (ttm)-1.88
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)131.4M
Total cash per share (mrq)2.54
Total debt (mrq)25.3M
Total debt/equity (mrq)21.67%
Current ratio (mrq)6.82
Book value per share (mrq)2.26

Cash flow statement

Operating cash flow (ttm)-66.72M
Levered free cash flow (ttm)-37.65M